RecallRadar

FDA Drug recall D-803-2013

Amoxicillin for Oral Suspension, USP 200 mg/5 mL, a) 75 mL bottle NDC 0093-4160-78 and b) 100 mL bottle NDC 0093-4160-73, Rx Only, Manufact…

On 2013-07-24 the FDA classified a Class III recall of Amoxicillin for Oral Suspension, USP 200 mg/5 mL, a) 75 mL bottle NDC 0093-4160-78 and b) 100 mL bottle NDC 0093-4160-73, Rx Only, Manufact… by Teva Pharmaceuticals Usa, citing discoloration: This recall is being carried out due to an orange to brown discolored Amoxicillin powder on the inner foil seal of the bottles. This is an expansion of RES 65050.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-803-2013
ClassificationClass III
Statusterminated
Initiated2013-06-18
Published2013-07-24
Last updated2026-09-13 11:51 UTC
CompanyTeva Pharmaceuticals Usa
DistributionUS

Product

Amoxicillin for Oral Suspension, USP 200 mg/5 mL, a) 75 mL bottle NDC 0093-4160-78 and b) 100 mL bottle NDC 0093-4160-73, Rx Only, Manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B2K9, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960.

Reason

Discoloration: This recall is being carried out due to an orange to brown discolored Amoxicillin powder on the inner foil seal of the bottles. This is an expansion of RES 65050.

Identifiers

ndc0093-2263-01
ndc0093-2264-01
ndc0093-4160-76
ndc0093-4160-78
ndc0093-4160-73
ndc0093-4155-79
ndc0093-4155-73
ndc0093-4155-80
ndc0093-4161-76
ndc0093-4161-78
ndc0093-4161-73
ndc0093-2267-01
ndc0093-2268-01
ndc0093-3107-01
ndc0093-3107-05
ndc0093-3109-53
ndc0093-3109-05
code_infoLot #s: a) 35426557A, 35426558A, Exp 08/14; b) 35426554A, 35426555A, 35426556A, Exp 08/14

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-803-2013%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.